Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, when Duodopa has been (a) routinely and (b) not routinely available for use on the NHS in England in each of the last five years.
Duodopa has never been routinely commissioned by NHS England.
NHS England assumed responsibility for directly commissioning specialised services in April 2013 and prior to this, responsibility for commissioning specialised services rested with the national NHS Specialised Services and the 10 regional specialised commissioning groups. Details of any consultations and commissioning decisions are not held centrally.